Abiopharma

New Form 8-K - LIXTE BIOTECHNOLOGY HOLDINGS, INC. Filed: 2025-06-17 AccNo: 0001641172-25-015346 Size: 391 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 11-K - DANAHER CORP /DE/ Filed: 2025-06-17 AccNo: 0000313616-25-000138 Size: 1 MB

New Form 8-K - Azitra, Inc. Filed: 2025-06-17 AccNo: 0001641172-25-015342 Size: 253 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MeiraGTx Holdings plc Filed: 2025-06-17 AccNo: 0001558370-25-008676 Size: 155 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Surgery Partners, Inc. Filed: 2025-06-17 AccNo: 0001638833-25-000117 Size: 329 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Aptose Biosciences Inc. Filed: 2025-06-17 AccNo: 0001171843-25-003935 Size: 194 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Marker Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001104659-25-060092 Size: 217 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Quantum Biopharma Ltd. Filed: 2025-06-17 AccNo: 0001171843-25-003936 Size: 15 KB

New Form 8-K - Ventyx Biosciences, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087068 Size: 275 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Spyre Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141756 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits